CASRAI Dictionary

Blog

  • NSPM-33 implementation: 18 months in

    National Security Presidential Memorandum 33, issued in 2021 and operationalised through implementation guidance during 2022-2024, requires US federal research-funding recipients to disclose certain affiliations, support, and resources from foreign sources, with the aim of identifying conflicts of commitment and undue foreign influence. The major federal agency rollouts (NIH, NSF, DOE, DOD, NASA, USDA) became binding through 2024 and 2025. We are now 18 months into substantive implementation. This post is a status report.

    What NSPM-33 requires

    The disclosure requirements run across three axes. Current and pending support: applicants must disclose all sources of support for ongoing and planned research activities, including foreign sources, with structured detail. Biographical sketch: applicants must list all affiliations, including foreign ones, in a structured format. Conflicts of interest and commitment: applicants must disclose financial conflicts of interest, foreign relationships, and any obligations to entities that could constitute conflicts of commitment.

    The structure is mostly common-form across agencies — the Common Forms work coordinated by NSTC’s Joint Committee on the Research Environment produced templated disclosure formats — though agency-specific variations persist. The CASRAI NSPM-33 entry tracks the common-form versions.

    What worked

    Three things have worked better than was expected at rollout.

    First, institutional infrastructure. Most major research universities built the disclosure-collection and -review infrastructure during 2022-2024 in anticipation of binding requirements. By the binding date, most had functional systems: faculty-facing tools for disclosure entry, research-administration review workflows, integration with proposal-submission pipelines. The smaller and less-resourced institutions struggled more, but the AAU- and APLU-coordinated capacity-building efforts substantially closed the gap.

    Second, the common-form approach. The Common Forms work was widely criticised during development for being slow and produced-by-committee. The result has held up well: a researcher applying to multiple agencies can use the same biographical sketch and current-and-pending-support disclosures with only minor agency-specific extensions. The pre-Common-Forms world had every agency requiring its own format; the post-Common-Forms world has substantial harmonisation.

    Third, the compliance posture. The major agencies have, on the whole, used the disclosure requirements as compliance tools rather than enforcement weapons. The early concerns about a wave of investigations leveraging disclosure inconsistencies as the predicate for action have largely not materialised. Where investigations have proceeded, they have done so in cases with substantive concerns beyond disclosure failures alone.

    What is broken

    Three implementation problems persist.

    First, retroactive disclosure. The requirements ask for disclosure of historical affiliations and support, often going back several years. Researchers have variable recollection and variable access to records of those years. Honest mistakes — forgotten honorary positions, misremembered dates, inaccurate amounts on past awards — produce disclosure inconsistencies that institutions then have to investigate and resolve. The investigation overhead is substantial; the underlying integrity concerns are usually minor.

    Second, international-collaboration chilling. The disclosure requirements have, in our community’s observation, produced a chilling effect on international collaboration, particularly with collaborators in countries that the US identifies as competitor jurisdictions. Researchers report declining collaboration invitations they would previously have accepted, in part to avoid the disclosure overhead, in part out of caution about how the disclosed activity might later be interpreted. The chilling effect is hard to measure but is widely reported.

    Third, the institutional-versus-individual line. The disclosure requirements ask the individual researcher to disclose their affiliations, but many “foreign affiliations” are institutional arrangements (university-to-university partnerships, MOUs, joint programmes) that the individual researcher discovers only when asked to disclose them. The institutional research administration knows the partnerships; the individual researcher often does not. Surfacing institutional partnerships in individual-disclosure workflows is an unsolved UX problem.

    The ORCID interlock

    One concrete improvement that NSPM-33 implementation has driven is tighter integration with ORCID as the canonical record of researcher affiliations. ORCID 4.0’s affiliation history with ROR IDs and date ranges is the natural source for the biographical-sketch component of NSPM-33 disclosures; agencies are increasingly accepting ORCID-derived biographical sketches and several are piloting direct ingestion from ORCID at submission. The CASRAI ORCID implementation guide has been updated with the NSPM-33 patterns.

    The longer-term value of this integration is that it incentivises researchers to maintain a current and complete ORCID record, which has benefits well beyond compliance. The institutions that have invested in ORCID adoption are well-positioned for NSPM-33 compliance; the institutions that have not are pushing researchers to maintain disclosure information in institutional systems that diverge from ORCID, creating a synchronisation problem.

    The CRediT angle

    NSPM-33 does not require CRediT roles in disclosures, but the disclosure framework’s interest in “all sources of support” includes contributions to research activities. A researcher who contributed to a foreign-funded project — even without being a PI — has a disclosure obligation. The CRediT role framework provides a vocabulary for characterising those contributions, and several institutional implementations now use CRediT-aligned controlled vocabularies in their disclosure forms.

    What’s still pending

    Three institutional adjustments are still in motion 18 months in.

    First, training and culture. The disclosure requirements need to become routine, the way IRB compliance has become routine. Most institutions still treat disclosure as a special workflow with episodic attention; the maturity target is that disclosure is built into hiring, promotion, sabbatical, and proposal workflows as a routine compliance item.

    Second, institutional-individual reconciliation. The institutional partnerships and the individual disclosures need to be reconciled systematically. Several institutions have built dashboards that show, for each researcher, the institutional partnerships their disclosed affiliations imply, with prompts for confirmation. This is the right direction; it is not yet widely deployed.

    Third, cross-institutional data sharing. When a researcher moves between US institutions, their disclosure history needs to travel with them. The current state is that it does not, reliably; the new institution rebuilds the disclosure profile from scratch. This is wasteful and produces unnecessary inconsistencies. ORCID-anchored disclosure portability is the right architectural answer; institutional adoption is the missing piece.

    What CASRAI recommends

    For research-administration offices, the priority for 2026 is to consolidate the operational maturity of disclosure workflows: routine integration with proposal submission, ORCID-anchored biographical sketches, institutional-partnership reconciliation, training programmes that treat disclosure as a standard compliance item. The CASRAI institutional research-security guide walks through the maturity model.

    For researchers, the operating posture is to keep ORCID current, to maintain a personal log of affiliations and support that supports disclosure, and to treat disclosure as part of professional practice rather than as exceptional compliance.

    For agencies, the priority is to continue the common-form harmonisation work and to consider further ORCID integration. The 2026 update to the Common Forms is in development and the indications are positive.

    Related dictionary entries

  • Diamond OA at the inflection: SciELO + Latindex + AmeliCA

    The Diamond OA conversation in 2026 is increasingly framed as a new direction for global scholarly publishing. From a Latin American perspective, this framing is roughly two decades late. SciELO, launched in Brazil in 1998, Latindex operating since 1995, Redalyc from 2003, and AmeliCA consolidating the regional infrastructure from 2018 — together these have operated a working Diamond OA ecosystem at regional scale for a quarter-century. This post looks at what the rest of the world is finally learning from this experience.

    The Latin American model

    The Latin American scholarly-communication model emerged from a different starting position than the Anglo-American one. Subscription publishing never dominated; commercial publisher penetration was limited; learned societies, universities, and national research councils operated journals as a public-good function. When the open-access conversation arrived in the 2000s, the question for Latin America was not how to flip a subscription system to OA but how to strengthen and federate the already-open infrastructure.

    SciELO emerged from FAPESP (the São Paulo research funder) and BIREME (the regional Pan American Health Organisation library) as a quality-controlled regional federation of journals with shared technical infrastructure, peer-review standards, and indexing. Latindex emerged from UNAM as a regional catalogue of scholarly journals with quality criteria. Redalyc emerged from the Universidad Autónoma del Estado de México as a full-text repository of Latin American journals. AmeliCA, launched in 2018, federated the three with explicit Diamond-OA positioning.

    The model is community-led, publicly funded, multilingual (Spanish, Portuguese, English, with growing Indigenous-language presence), and operates without article-processing charges. It indexes thousands of journals; the federated catalogue holds over a million articles; the technical infrastructure (XML production, DOI registration, COUNTER-compliant usage statistics) meets international standards.

    What worked, and why

    Three structural features explain the model’s durability.

    First, institutional anchoring. SciELO, Latindex, Redalyc, and AmeliCA are each hosted by major research institutions (FAPESP, UNAM, UAEM) with stable funding. The infrastructure is not project-grant-dependent; it is institutionally sustained. This is the contrast with the European Diamond OA conversation, which has struggled with project-grant precarity, and one of the lessons that the 2024 Plan Diamond declaration explicitly acknowledged.

    Second, quality through federation. The journal-level quality criteria (Latindex’s catalogue criteria, SciELO’s collection criteria) are operated as community-standards bodies, not as gatekeepers. A journal that meets the criteria is indexed; the criteria are public; appeals are possible. The federated catalogue is the quality signal; reputation is built through inclusion rather than through individual journal brand.

    Third, technical infrastructure shared at scale. The SciELO publishing infrastructure (XML production, web hosting, DOI registration) is offered as a service to participating journals. Journals do not each reinvent the technical layer. This reduces per-journal cost dramatically and is the model that the European Diamond OA capacity centre is now trying to replicate.

    What the global North is learning

    Three lessons are being absorbed, slowly.

    First, institutional funding is the sustainable model. APC-based gold OA reproduces commercial publishing’s economics; transformative agreements concentrate funding in well-resourced consortia; Diamond OA funded by institutions is the cost-effective alternative for the scholarly-communication public good. The OPERAS network in Europe, the cOAlition S 2024 strategic refresh, and the MIT Framework on principles for scholarly communication all explicitly endorse institutional funding for OA infrastructure.

    Second, bibliodiversity is a feature, not a bug. The Latin American model publishes in multiple languages, with regional editorial leadership, addressing regional research priorities. The dominant-language, Global-North-centred model that emerged from the subscription era is a historical accident, not a quality standard. The bibliodiversity framing from the Jussieu Call (2018), the Helsinki Initiative on Multilingualism in Scholarly Communication (2019), and the UNESCO Recommendation on Open Science (2021) all draw on the Latin American experience.

    Third, regional infrastructure is legitimate research infrastructure. The bibliometric assessment patterns that treated SciELO and similar venues as second-tier indexing did so on assumptions (Web of Science and Scopus as global standards) that are themselves historically and geographically specific. The 2024 Helsinki Initiative implementation guidance and the CoARA reform agenda push assessment systems to recognise regional infrastructure on its own terms.

    What still needs work

    The Latin American model is not without its tensions. Three deserve mention.

    First, discoverability beyond the region. SciELO is indexed in major international databases; Latindex and AmeliCA less so. Articles published in regional Diamond OA venues are findable to those who know to look there; less findable to those defaulting to Web of Science or Scopus. The integration with Crossref and DataCite has improved this, but the discovery-default question remains.

    Second, discipline coverage. The Latin American Diamond OA ecosystem is stronger in humanities, social sciences, and applied health than in laboratory natural sciences and engineering, where researchers under bibliometric pressure publish externally. The model needs reinforcement in disciplines where it is currently thinner.

    Third, language equity within the region. Indigenous-language and Portuguese publication is growing but is still well behind Spanish. The 2024 AmeliCA strategic refresh prioritises multilingual expansion.

    What CASRAI recommends

    For Global North funders and institutions considering Diamond OA investment, the operating advice is to learn from the Latin American experience and to support, where possible, integration with the existing regional infrastructure rather than build parallel structures. The 2024 Plan Diamond signatory commitments include several explicit channels for funding regional infrastructure; the CASRAI Diamond OA funder guide walks through the options.

    For institutions evaluating their researchers’ contributions, the operating advice is to recognise publication in regional Diamond OA venues on the same terms as publication in international venues. This requires updating bibliometric tools to include the regional indices, updating promotion-and-tenure committees’ reading lists, and treating responsible assessment commitments seriously rather than performatively.

    For researchers, the operating advice is to publish where the work fits the venue, not where the bibliometric pressure points. A regional-language paper in a SciELO or Redalyc journal is a legitimate scholarly output and should be claimed and cited as such. The CASRAI bibliodiversity for authors guide discusses the practicalities.

    The longer arc

    The next ten years of scholarly publishing will be shaped by whether the global system absorbs the Latin American lessons or continues to treat them as regional exceptions. The signs are tentatively positive. cOAlition S’s strategic refresh, the OPERAS work in Europe, the institutional re-investment as transformative agreements expire — all point toward a less commercial, less APC-centred, more bibliodiverse system. The infrastructure to operate that system already exists in Latin America; the rest of the world is catching up.

    Related dictionary entries

  • CARE-FAIR tension and how the GIDA Manifesto resolves it

    The CARE Principles for Indigenous Data Governance (Collective benefit, Authority to control, Responsibility, Ethics) and the FAIR data principles (Findable, Accessible, Interoperable, Reusable) are often presented as complementary. In practice they have a real tension: FAIR maximises openness and access; CARE centres Indigenous community authority over data, including over what counts as accessible and to whom. The Global Indigenous Data Alliance’s 2024 manifesto on CARE-FAIR integration is the most developed framework for reconciling them. This post walks through the tension, the GIDA Manifesto’s resolution, and what implementers should do.

    What FAIR says and what it does not

    FAIR, articulated by Wilkinson and colleagues in 2016, is a framework for making data more useful. Findable: data have rich metadata and persistent identifiers. Accessible: data can be retrieved by an authentication-and-authorisation protocol that is open and free. Interoperable: data use shared vocabularies and standards. Reusable: data have clear provenance, licensing, and usage information.

    What FAIR does not directly address is who decides what is findable, accessible, interoperable, and reusable. FAIR is technically permissive about access controls — the principles allow that authentication-and-authorisation may restrict access — but the dominant interpretation of FAIR has been maximalist: open by default, restricted only with clear justification. This has produced an implementation pattern where Indigenous data are often treated as candidates for openness with restrictions, rather than as community-governed assets whose access decisions sit with the community.

    What CARE says

    The CARE Principles, articulated by the Global Indigenous Data Alliance in 2019 and formally published in 2020, are a counterweight rather than a contradiction of FAIR. Collective benefit: data ecosystems are designed and function in ways that enable Indigenous peoples to derive benefit from the data. Authority to control: Indigenous peoples’ rights and interests in Indigenous data must be recognised, and they must have the authority to control such data. Responsibility: those working with Indigenous data have a responsibility to share how those data are used. Ethics: Indigenous peoples’ rights and wellbeing should be the primary concern at all stages of the data lifecycle.

    CARE applies to Indigenous data, defined broadly to include data about Indigenous peoples, Indigenous lands, Indigenous resources, and Indigenous knowledge. The principles are not anti-openness; they are pro-authority-with-the-community-on-openness-questions.

    The tension in practice

    Three illustrative tensions.

    First, a researcher working with an Indigenous community produces a dataset documenting traditional ecological knowledge. FAIR-maximalist implementation would push for open deposit with a CC BY licence. CARE-aligned implementation would defer to the community’s governance: the community may choose to share openly, may choose to share with use restrictions, may choose to restrict access entirely, may choose to share with attribution requirements via Traditional Knowledge Labels. The community’s decision is determinative under CARE; the FAIR-maximalist instinct is to nudge toward openness.

    Second, a population health dataset includes Indigenous community-level data. FAIR-maximalist implementation would push for de-identified open deposit. CARE-aligned implementation asks whether de-identification is sufficient to prevent community-level identification (often it is not), whether the community has consented to research uses beyond the original study, and whether the planned uses generate collective benefit. The answers may permit open deposit, may require controlled access, or may require negotiated terms.

    Third, a museum collection includes Indigenous cultural objects with associated metadata. FAIR-maximalist implementation would push for full metadata openness. CARE-aligned implementation defers to the community on what metadata is appropriate to share, what should be retained but restricted, and what should be returned to community governance.

    The GIDA Manifesto

    The GIDA Manifesto on CARE-FAIR integration, published in 2024 after extended consultation across the international Indigenous data networks (Te Mana Raraunga in Aotearoa New Zealand, Maiam nayri Wingara in Australia, the United States Indigenous Data Sovereignty Network, the First Nations Information Governance Centre in Canada, and others), articulates a reconciliation framework.

    The framework’s core proposition is that FAIR and CARE are sequenced, not simultaneous. CARE comes first: the community’s governance decisions determine what data exist, who has rights in them, what uses are permitted, and what access conditions apply. FAIR then operates within the CARE-determined envelope: findable to those who should find them, accessible under the access conditions the community has set, interoperable for the uses the community has permitted, reusable subject to community-defined terms.

    This is not a watering-down of FAIR; the manifesto is explicit that all four FAIR principles are honoured within their proper scope. It is a re-ordering of the implementation question. The pre-FAIR step is not assumed-open; it is community-determined.

    Operational implications

    For repositories, the operational implications are concrete. Repositories holding or potentially holding Indigenous data need governance arrangements that surface CARE compliance. This means: identifying Indigenous data at deposit; verifying community authorisation; recording the community’s access decisions in machine-readable form; honouring those decisions in the access-control layer; providing for community-initiated access changes over time.

    The CASRAI Indigenous data and CARE domain tracks repository implementations. Several have led: the SOLES repository at the Smithsonian, the Indigenous-managed nodes of the OCAP-aligned First Nations data ecosystem in Canada, the Maori Data Sovereignty Network’s portal in Aotearoa New Zealand.

    For researchers, the operational implications are about partnership. Research that produces Indigenous data needs to be conducted in partnership with the community, with data-governance arrangements agreed upfront, with the community holding control over downstream uses. The Free, Prior, and Informed Consent framework is the standard reference.

    For funders and journals, the operational implications are about review and policy. Funder data-management requirements should recognise CARE-aligned deposit; journal data-availability requirements should accommodate community-governed access decisions. Several major funders and journals have updated their policies in 2024-2025 to do this; the implementation is uneven.

    The OCAP and FPIC interfaces

    Two adjacent frameworks deserve mention. OCAP (Ownership, Control, Access, Possession), articulated by the First Nations Information Governance Centre in Canada, predates CARE and operates in a more granular operational space; OCAP and CARE are compatible and OCAP-aligned implementations can claim CARE alignment in the relevant scope. FPIC is the consent framework derived from the UN Declaration on the Rights of Indigenous Peoples; FPIC operates at the research-design stage, before data are collected, and is upstream of both CARE and FAIR.

    The integrated operational pattern: FPIC governs research design and data collection; OCAP governs the data-control arrangements during and after collection; CARE provides the data-governance framework for repository-level and ecosystem-level decisions; FAIR provides the technical-implementation framework for the openness-within-CARE-envelope work.

    What CASRAI recommends

    Four recommendations. First, repositories should adopt CARE-aligned governance, with community-controlled access decisions surfaced in the deposit and discovery layers. Second, researchers working with Indigenous communities should structure partnerships under FPIC and follow OCAP or equivalent arrangements. Third, funders and journals should recognise CARE-aligned deposit as fulfilling data-availability requirements. Fourth, the FAIR-data community should adopt the GIDA Manifesto’s sequencing as the default implementation pattern, with the FAIR-first interpretation explicitly identified as inappropriate for Indigenous data.

    The reconciliation works. It requires more upfront attention to governance than the FAIR-maximalist default, but it produces outcomes that respect community sovereignty while delivering the technical-interoperability benefits that FAIR was designed for.

    Related dictionary entries

  • How to write a CRediT statement for medical research in 2026

    Medical-research contributorship sits at an awkward intersection. The International Committee of Medical Journal Editors (ICMJE) still defines who may sign as an author of a clinical paper through its four-part test: substantial contribution to conception/design or acquisition/analysis/interpretation; drafting or critical revision; final approval; and accountability. CRediT, the Contributor Roles Taxonomy that CASRAI helped steward into NISO Z39.104-2022, sits underneath and describes what each named contributor actually did. In 2026, after another wave of journal adoption and the long-anticipated alignment with ORCID’s contributor affiliation model, a CRediT statement is no longer a discretionary nicety. It is the contributorship record of the paper.

    This post walks through how to write a CRediT statement that satisfies a medical journal’s submission system in 2026, with attention to the editorial conventions of NEJM, The Lancet, JAMA, and The BMJ. It assumes you have already worked out who meets the ICMJE authorship threshold; see our medical-research authors guide for that step.

    Authorship versus contributorship: not the same question

    The first error we see in submissions is conflating ICMJE authorship with CRediT contributorship. ICMJE answers a binary: does this person qualify to be listed as an author and to be accountable for the work? CRediT answers a granular: of the people who are listed, who did what? A statistician who ran the analysis but did not draft or revise may not meet ICMJE criteria and is acknowledged separately; if they do meet ICMJE criteria, then their CRediT role assignment would include Formal analysis, possibly Methodology, possibly Software, and they would be named on the byline. Liz Allen and the team that originated CRediT at Wellcome Trust were explicit on this distinction; the taxonomy was designed to complement, not replace, journal authorship rules.

    For medical research the second confounder is the guarantor. The BMJ has long required a named guarantor in addition to authors, and other ICMJE-following journals encourage the convention for clinical trials. The guarantor sits outside CRediT; it is closest in spirit to the Supervision role plus an accountability commitment, but it is not encoded in the taxonomy. In your CRediT statement, name the guarantor in a separate sentence; do not invent a Guarantor role.

    The 14 roles in medical-research context

    CRediT’s 14 roles were drafted for general research and need a brief translation when applied to clinical work. The full role definitions are normative; what follows is interpretive guidance, not a redefinition.

    • Conceptualization. The research question. For a registered clinical trial this is often a Principal Investigator role; for a secondary analysis it may be a junior contributor with a novel hypothesis.
    • Methodology. Study design, choice of endpoints, statistical-analysis-plan structure. A trial statistician contributing to the SAP earns this role even if a different person ran the final analysis.
    • Software. Programming for data capture (REDCap configuration counts), randomisation code, custom statistical packages, any analytic script that materially shaped results.
    • Validation. Reproduction of analyses, sensitivity analyses, cross-checks against an independent dataset. Often a co-author who replicates the lead analyst’s work.
    • Formal analysis. The statistical analysis itself.
    • Investigation. Recruitment, screening, consenting, clinical assessments, sample collection. Often the largest list of contributors in multi-site trials.
    • Resources. Provision of patient samples, biobanks, animal models, instrument time. Distinct from Funding acquisition.
    • Data curation. Data cleaning, harmonisation, query resolution, lock-down.
    • Writing – original draft. First-draft authorship of the manuscript.
    • Writing – review & editing. Substantive editorial revision, not copy-editing.
    • Visualization. Figures, including Kaplan-Meier curves, forest plots, CONSORT flow diagrams.
    • Supervision. Mentorship and oversight, often the senior author. A PI typically combines Supervision with Conceptualization and Funding acquisition.
    • Project administration. Coordination across sites, ethics submissions, sponsor liaison.
    • Funding acquisition. Grant-writing for the funded work.

    The lead/equal/supporting qualifier

    Adopted formally into NISO Z39.104 and now widely supported, the degree-of-contribution qualifier resolves a recurring source of disputes. For each role, exactly one contributor may be marked Lead, or several may be marked Equal; everyone else for that role is Supporting. In a multi-site oncology trial it is realistic to have a Lead Investigator (the coordinating PI), several Equal Investigators (site PIs), and a longer list of Supporting Investigators (sub-investigators, research nurses who meet ICMJE thresholds). The qualifier exists precisely so that the byline order does not have to encode contribution magnitude.

    Writing the statement

    A 2026-compliant CRediT statement is rendered as prose in the manuscript and as structured data in the submission system. Most major medical journals now extract the structured form from their submission portal directly; the prose paragraph is for the published version. Here is a worked example for a four-author RCT report:

    CRediT author statement. Sarah Chen: Conceptualization (lead), Methodology (lead), Funding acquisition (lead), Supervision (lead), Writing – review & editing (equal). Marcus Okonkwo: Investigation (lead), Project administration (lead), Data curation (lead), Writing – original draft (lead). Priya Raman: Formal analysis (lead), Software (lead), Validation (lead), Visualization (lead), Writing – review & editing (equal). David Holcombe: Methodology (supporting), Investigation (supporting), Writing – review & editing (supporting), Supervision (supporting). Guarantor: Sarah Chen.

    Note the explicit guarantor statement, separate from CRediT. Note also that not every role appears; Resources was inapplicable here and should be omitted rather than padded.

    JATS XML output

    For machine-actionable contributorship, journals serialise CRediT into JATS XML using the <role> element with the vocab="credit" attribute and the canonical role URI. The 2022 NISO version pinned the URIs at https://credit.niso.org/contributor-roles/<role-slug>/ with the qualifier expressed via specific-use="lead|equal|supporting". As an author you do not write the JATS by hand; you fill in the submission portal and the publisher’s tooling renders the XML. Where things go wrong is the round-trip: if the published HTML drops the qualifier, the JATS may also drop it and downstream Crossref deposits will be incomplete. If you care about the persistent record, check the published JATS via the publisher’s content syndication endpoint after acceptance.

    Journal-specific notes

    NEJM

    The New England Journal of Medicine adopted CRediT in late 2023 and integrated it into its Editorial Manager workflow in 2024. NEJM’s idiosyncrasy is that it still asks separately for the prose contribution statement, then asks each author to confirm their CRediT roles, and finally requires a writing-assistance declaration that is not CRediT (it covers professional medical writers funded by sponsors). Do not list a paid medical writer who does not meet ICMJE criteria under CRediT Writing – original draft; declare them in the acknowledgements with the funding source per Good Publication Practice (GPP 2022).

    The Lancet

    The Lancet was an early CRediT adopter and was unusual in coupling the taxonomy to a long-standing requirement for each author to write a one-sentence prose contribution statement in their own words. Both are retained in 2026. The prose statement is what readers see in the printed acknowledgements; the structured CRediT data lives in the JATS and in Crossref. For a Lancet submission, write the structured assignment first and then have each author translate their own roles into a single readable sentence.

    JAMA

    JAMA and the JAMA Network journals adopted CRediT in 2022 and tied it tightly to ORCID; an author without a verified ORCID iD cannot complete the contributorship form. JAMA also asks for explicit role assignments for Statistical analysis, Obtained funding, and Administrative, technical, or material support; these are journal-specific role labels that overlap with CRediT but are tracked separately for editorial QA. If you have a Formal analysis role under CRediT you must also tick Statistical analysis on the JAMA form, otherwise the submission will not validate.

    The BMJ

    The BMJ adopted CRediT in 2023 and retained its long-standing guarantor requirement on top. BMJ’s submission system asks for the CRediT roles in structured form and then asks the corresponding author to identify the guarantor by name. The published article carries both: the CRediT statement as prose, and the guarantor sentence beneath it. BMJ also continues to require declarations of relationships and activities (the BMJ-specific competing interests format) which sit alongside but separately from CRediT.

    Common failure modes

    Three patterns recur in submissions to medical journals. First, role inflation: assigning Conceptualization to every author by reflex. CRediT is a record, not a recognition device; if a co-author did not contribute to conceptualisation, do not assign that role. Second, byline order substituting for qualifiers: a paper with five equal first-authors should mark all five as Equal on the roles they share, not just rely on a footnote saying “these authors contributed equally.” Third, missing the writing roles: every paper has someone who wrote the first draft. If your CRediT statement omits Writing – original draft, the editor will ask.

    Adoption status and trajectory

    As of early 2026 the CRediT adoption ledger records 70+ publishers with active CRediT support and structured submission workflows in most major medical and biomedical journals. The ICMJE has not made CRediT mandatory across its full membership, but its 2024 update to the Recommendations explicitly endorses CRediT as an acceptable mechanism for describing contributions, and several ICMJE journals require it. Outside ICMJE, the trajectory is the same: PLOS, Cell Press, Springer Nature, Wiley, Taylor & Francis, Elsevier, OUP, CUP, and a long tail of society publishers now require structured CRediT at submission.

    What to do next

    If you are preparing a submission, work through these in order: (1) settle the authorship list against ICMJE criteria; (2) draft the CRediT role assignment in a shared document with qualifiers; (3) have each author confirm their roles in writing before submission; (4) enter the structured data in the submission portal and copy the prose statement into the manuscript; (5) declare the guarantor and any medical writers separately. The CASRAI CRediT authors guide contains a downloadable role-assignment worksheet that has saved more co-author disputes than any other artefact we publish.

    Related dictionary entries

    References

    ICMJE, Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (2024 update). NISO Z39.104-2022, CRediT, Contributor Roles Taxonomy. Allen et al., Nature (2014), Publishing: Credit where credit is due. Brand et al., Learned Publishing (2015), Beyond authorship: attribution, contribution, collaboration, and credit. Holcombe, Publications (2019), Contributorship, not authorship.

  • What ‘broader impacts’ means under the new NSF policy

    The US National Science Foundation’s broader-impacts criterion, in force since the mid-1990s and refreshed periodically since, received its most significant revision in 2024 with rolling implementation through 2025-2026. The new policy sharpens what counts as a credible broader-impacts plan, what evidence applicants need to provide, and how reviewers should weight the criterion. This post is a practical orientation for applicants and research-administration offices handling NSF proposals in 2026.

    Broader impacts, briefly

    NSF merit review uses two co-equal criteria: intellectual merit (the scientific value of the proposed work) and broader impacts (the benefits to society beyond the immediate science). Broader impacts can be of many kinds: education and training of students, public engagement, infrastructure development, dissemination beyond peer-reviewed venues, increased participation of under-represented groups in STEM, partnerships with industry or non-academic users, contributions to national interests including economic competitiveness and security.

    The criterion has been criticised since its introduction for being weakly evaluated, for being treated as an afterthought to intellectual merit, and for accepting plausibility statements in lieu of evidence-based plans. The 2024 revision is the NSF’s response to those criticisms.

    What the new policy changes

    Three substantive changes.

    First, evidence-based planning. The new policy expects broader-impacts plans to be grounded in evidence from the broader-impacts and informal-STEM-learning literature. An applicant claiming that a proposed K-12 outreach activity will improve student interest in science needs to ground that claim in published evidence about what works in K-12 STEM engagement, not just assert it. The policy explicitly references the work of Bevan, Falk, Dierking, and others in the informal-learning research community.

    Second, measurable outcomes. Plans must specify what success looks like in observable terms, what data will be collected to assess success, and how the assessment will be conducted. Vague aspirations (“will inspire the next generation of scientists”) are not sufficient; observable indicators are required. The policy stops short of requiring randomised controlled trials of outreach activities but moves substantively toward evaluation rigour.

    Third, integration with intellectual merit. The policy emphasises that broader impacts should be substantively connected to the research, not bolted on as a separable activity. A proposal whose broader-impacts plan is a generic education-outreach activity unrelated to the science is now explicitly weaker than a proposal whose broader-impacts plan extends the science in directions that benefit specific communities.

    What this means for applicants

    The practical implications. First, build the broader-impacts plan into the proposal narrative, not into a separate annex. Show the connection between the science and the broader impact. The CASRAI NSF applicant guide walks through structural patterns that integrate the two.

    Second, cite evidence. If you propose outreach to under-represented groups, cite published evidence about effective interventions for those groups. If you propose a teacher-development workshop, cite the literature on effective teacher development. The expectation is not that applicants become broader-impacts researchers; it is that the plan is grounded in someone’s research, with citations.

    Third, specify the assessment. What will you measure? How will you measure it? Who will analyse the data? A typical strong assessment specifies: outcome measure (e.g., self-reported student interest in STEM career on a validated instrument); data collection (pre/post survey administration); analysis plan (paired-difference test with effect-size reporting); reporting venue (project annual report plus a conference paper).

    Fourth, partner with people who do this work. Researchers who are not broader-impacts specialists should partner with informal-STEM-education professionals, with community-engagement specialists at their institution, with K-12 educators who can co-design and assess interventions. The partnerships should be visible in the proposal: who is doing the work, what their qualifications are, what their role is.

    What this means for research administration

    Research-administration offices supporting NSF proposals should be upskilling around the new policy. Three priorities. First, build a broader-impacts library: a curated set of evidence-based plans, vetted partners, and assessment instruments that researchers can adapt. Second, offer structured proposal-development support that includes broader-impacts review by someone qualified to assess the evidence base. Third, support post-award assessment: the broader-impacts assessment plans now in proposals need to be executed during the award and reported in the final project report.

    The CASRAI institutional broader-impacts guide includes a checklist for research-administration offices building this capacity.

    How reviewers should evaluate

    NSF’s revised reviewer guidance asks reviewers to evaluate broader impacts on the same evidence-based and outcome-specified terms. A reviewer should ask: is the plan grounded in evidence? Are the outcomes measurable? Is the assessment credible? Is the broader-impacts work integrated with the research?

    This is a substantive shift. Pre-2024 reviewer guidance often produced broader-impacts ratings that reflected the reviewer’s gestalt impression of the applicant’s commitment. The new guidance pushes toward more analytic evaluation, with the explicit recognition that broader impacts is a domain with its own expertise and its own literature.

    The wider implications

    Three wider implications worth noting.

    First, the policy normalises broader-impacts research as a discipline. NSF has historically funded broader-impacts research thinly; the new policy implicitly raises the visibility of the field and the demand for its outputs. We expect funding for broader-impacts research itself to increase in subsequent budget cycles.

    Second, the policy aligns with the international move toward structured impact reporting. The UK’s Research Excellence Framework impact case studies, the EU’s Horizon Europe expected-impact framework, and several other funder frameworks all push in similar directions. CASRAI’s engagement, impact, and SDG domain tracks the international landscape.

    Third, the policy creates a soft incentive toward partnerships between research-intensive universities and the institutions (community colleges, K-12 systems, science museums, community organisations) that have broader-impacts capacity. The partnerships, where they work, are mutually beneficial; where they do not, broader impacts becomes a service-delivery problem dressed as a research-grant activity.

    Open questions

    Two open questions for 2026 and beyond. First, the resource implications: an evidence-based broader-impacts plan with a real assessment costs money, sometimes a substantial fraction of the project budget. NSF has signalled that meaningful broader-impacts costs are budgetable and reviewable on their merits, but the budget pressure is real, particularly for small grants. Second, the equity implications: applicants from research-intensive universities have easier access to broader-impacts capacity than applicants from less-resourced institutions. The new policy may inadvertently widen the gap between institution categories. NSF is aware of this risk and the next policy update is expected to address it.

    For applicants in 2026, the operating posture is to take the new policy seriously, partner with people who do this work, ground your plan in evidence, specify the assessment, and integrate broader impacts with the research. The bar has risen; the proposals that clear it will be substantially stronger than the pre-2024 baseline.

    Related dictionary entries

  • GenAI in scholarly authorship: the 2026 disclosure landscape

    The 2023 ICMJE position that generative AI cannot be a co-author has aged into a stable consensus across scholarly publishing, but the implementation surface around it has grown fast. In 2026 the question is no longer whether to disclose AI use in a manuscript; it is how, where, and with what evidence. This post maps the current disclosure landscape, the technical mitigations that publishers expect authors to apply, and the residual uncertainty around detection.

    The ICMJE 2023 position and its echoes

    In January 2023 the ICMJE updated its Recommendations to add that chatbots cannot be authors because they cannot meet the accountability criterion: an LLM cannot take responsibility for the integrity of the work, cannot approve the final version in any meaningful sense, and cannot be contacted by readers seeking clarification. The position was endorsed within weeks by the World Association of Medical Editors and by COPE. By mid-2023 every major publisher had aligned. The AI co-authorship rejection is now treated as a settled norm.

    What replaced the brief flurry of “ChatGPT as co-author” papers was a more nuanced question: how should authors disclose AI use when the system is a tool? This is where 2024 and 2025 brought significant fragmentation, and where 2026 has begun to consolidate.

    The publisher landscape in 2026

    Nature and the Springer Nature stable

    Nature requires authors to declare any use of LLMs in the Methods section (for research articles) or in the acknowledgements (for editorial and review content). The declaration must specify the model, the version, the date of use, and the purpose. Nature does not permit AI-generated images or figures except where the AI generation itself is the subject of the research. Springer Nature has cascaded a similar policy across its journals with light variation.

    Cell Press and Elsevier

    Cell Press and Elsevier journals require disclosure of AI-assisted writing in a dedicated declaration that sits alongside competing interests and funding. The declaration is structured: type of tool, purpose (e.g., language polishing, literature search, code generation, image analysis), and a confirmation that the authors take full responsibility. Elsevier additionally requires that AI-generated text be reviewed and edited by the authors and explicitly forbids using AI for peer review.

    Wiley

    Wiley’s policy distinguishes between using AI as a tool (allowed with disclosure) and using AI to generate substantive intellectual content (not allowed). The distinction is fuzzy at the boundary, and Wiley’s submission system asks authors to self-classify. Wiley also publishes its Best practice guidelines on research integrity and publishing ethics which were updated in 2024 to cover GenAI in detail.

    PLOS, eLife, F1000Research

    The open-publishing platforms have generally taken the position that AI use must be disclosed and that authors are responsible for verification, but they have been more permissive about disclosed and reviewed AI use than the closed-access incumbents. eLife in particular has experimented with AI-assisted peer review summaries, with disclosure to authors and readers.

    What “disclosure” actually requires

    The fragmentation across publisher policies has converged on a common five-element disclosure, which CASRAI’s AI disclosure helper assembles into a publisher-specific declaration:

    1. Tool and version. Not “ChatGPT” but “GPT-4o (OpenAI), version of 2025-12-04.”
    2. Purpose. One of: language polishing, translation, literature search, code generation, data extraction, image analysis, hypothesis generation, draft writing. If the use spanned multiple purposes, list each.
    3. Scope. Which sections or artefacts were involved. “Abstract and discussion polished” is meaningfully different from “first draft written.”
    4. Human verification. A statement that named authors have reviewed and verified the output and take responsibility for it.
    5. Prompt and output retention. Increasingly, journals are asking authors to retain prompts and outputs for audit. Cell Press now formally asks; Nature recommends. Treat this as a 5-year retention obligation.

    See our AI disclosure for authors guide for the publisher-by-publisher decision tree.

    The hallucination problem

    The single largest editorial concern in 2026 remains hallucination: an LLM fabricating a citation, a method, or a result and the authors failing to catch it. Retraction Watch tracked over 200 retractions in 2024 and 2025 attributable in whole or part to undisclosed AI-generated fabrications, primarily fictitious references but increasingly fabricated quantitative results in tables.

    The mitigations are well-known and surprisingly under-applied:

    • Citation verification. Every citation in an LLM-generated draft must be checked against the actual source. Tools like Scite, Semantic Scholar’s citation graph, and Crossref’s metadata API help. The bare minimum: every DOI must resolve and the paper at that DOI must say what the LLM claims.
    • Numerical verification. If an LLM produces a number, the human author must reproduce the number from the underlying source. “The LLM said it” is not provenance.
    • Retrieval-augmented generation (RAG). Grounding an LLM in a fixed corpus of verified sources, with citation chaining, reduces but does not eliminate hallucination. RAG-based research-writing tools (Elicit, Consensus, scite Assistant) have an accuracy edge over raw LLMs precisely because they constrain the model to a verifiable corpus.

    Munafò and colleagues at the UK Reproducibility Network have argued, correctly in our view, that AI-assisted writing should sit inside the same reproducibility envelope as the rest of the work: prompts and outputs are part of the methods, not part of the prose.

    Detection and watermarking

    The detection problem has not been solved. Tools that claim to identify AI-generated text by perplexity or burstiness have unacceptable false-positive rates against careful human writers and are easily defeated by simple paraphrasing. AI-assisted writing is, on the open web, essentially undetectable in 2026.

    Three more promising directions exist. First, watermarking: the major LLM providers have prototyped statistical watermarks (Google’s SynthID-Text, OpenAI’s research-stage text watermark) that embed a detectable signal in token-selection statistics without affecting fluency. Adoption has been slow because authors can defeat watermarks by re-rolling with a different model, and because no publisher has committed to refusing un-watermarked submissions. Second, provenance metadata: the C2PA standard (originally for images) is being extended to text, with cryptographically signed assertions of generation source. Third, process auditing: rather than detecting AI in the output, audit the authors’ process artefacts (version history, prompt logs, draft trail). This is the direction in which institutional integrity offices are moving.

    For authors, the practical takeaway is that you should not rely on undetectability. The conservative path is disclosure plus verification.

    What about peer review?

    The 2026 consensus is that peer reviewers may not paste unpublished manuscripts into a third-party LLM. The reason is confidentiality, not anti-AI sentiment: a paper under review is privileged information and most LLM providers retain inputs in some form. NIH and several large funders have made this an explicit policy for proposal review; publishers are catching up. eLife and a handful of others are experimenting with publisher-hosted LLM tooling that does not exfiltrate the manuscript, which threads the needle.

    Where this is going

    Three trajectories are visible. First, the disclosure form will converge: expect a NISO or COPE-led standardisation of GenAI disclosure within 18-24 months, modelled on the structured CRediT statement. Second, prompt-and-output retention will become mandatory for high-stakes journals (clinical, regulatory-relevant), and audited at random. Third, the line between “AI as tool” and “AI as substantive contributor” will be tested by hybrid systems where the human author’s contribution is curation, framing, and verification rather than generation. We expect the integrity community to draw a harder line on quantitative and methodological substance than on prose: an AI may polish your discussion section with disclosure, but an AI may not propose your analytic method without that proposal being independently validated and disclosed.

    For now, the operating rule is straightforward. If you used AI, disclose it specifically. If the AI produced text or numbers in your paper, verify them yourself. If a publisher asks for prompts and outputs, retain them. If you are reviewing a paper, do not paste it into a chatbot. The GenAI disclosure domain at CASRAI tracks the publisher-by-publisher policy text for authors who need to comply across multiple submission targets.

    Related dictionary entries

    References

    ICMJE, Recommendations (January 2023 update, defining authorship to exclude AI). WAME, Chatbots, ChatGPT, and Scholarly Manuscripts (2023). COPE, Authorship and AI tools position statement (2023, reaffirmed 2025). Nature editorial, Tools such as ChatGPT threaten transparent science; here are our ground rules for their use (2023). Munafò et al., The reproducibility debate is an opportunity, not a crisis (PLOS Biology, 2022).

  • Persistent identifiers in 2026: ORCID + ROR + RAiD + DOI

    By 2026 the persistent-identifier (PID) layer of scholarly infrastructure has stabilised into a quartet: ORCID for people, ROR for organisations, RAiD for projects, and DOI for almost everything else (articles, datasets, software, instruments, samples, preregistrations). Each is operationally distinct, each has its own governance, and the seams between them are where most metadata loss still happens. This post is a tour of the state in early 2026, the integrations that work well, and the crosswalk gaps that institutions and publishers are still grinding through.

    ORCID at 2 million+ active iDs and counting

    The Open Researcher and Contributor iD is by some distance the most successful PID for people. As of 2026, ORCID reports over 21 million registered iDs with active use across publishing, funding, and institutional workflows. The 2024 integration of CRediT at the ORCID-record level was the missing piece that closed the loop: a contributor’s roles on a specific work can now be carried persistently on their ORCID record, not just in the publisher’s JATS.

    The CASRAI-stewarded contribution to ORCID’s data model also added affiliation history with PIDs (ROR for the organisation, RAiD for projects, DOI for grants), which means a complete ORCID record now resolves the four-way join. The ORCID federation page at CASRAI documents the per-country member organisations and the institutional integration patterns; the ORCID implementation page documents the technical integration via the public API and the member API.

    What’s still hard with ORCID in 2026

    Coverage is uneven by discipline. Life sciences and physics push close to saturation; humanities, education, and applied fields still have large populations who have not registered. Coverage is also uneven by career stage: PIs are nearly universal, postdocs and senior researchers have high coverage, graduate students and undergraduate contributors are sparse. The policy question of whether to require ORCID at submission, mandate it for funding eligibility, or leave it voluntary remains contested; the major medical journals (NEJM, JAMA, BMJ, Lancet) effectively require it for corresponding authors, the broader landscape does not.

    ROR: the organisational identifier that finally worked

    The Research Organization Registry launched in 2019 and crossed 100,000 active records around 2023. By 2026 ROR is the default organisational PID across Crossref, DataCite, ORCID, and most institutional CRIS systems. The decision to keep ROR governance light, the data open under CC0, and the IDs free at all volumes has been validated by adoption.

    ROR replaced a Babel of organisational identifiers (GRID, ISNI for orgs, ad-hoc Crossref Funder Registry entries, individual database keys at each tool). The integration pattern is clear: every author affiliation should resolve to a ROR ID, and that ID should travel through the metadata to Crossref, DataCite, ORCID, and the institutional repository. Most publishers now require or strongly prefer ROR at submission.

    ROR’s main 2025-2026 work has been on hierarchies: capturing the parent/child relationships between research institutions, hospitals, university systems, and consortia in a queryable way. A hospital with an academic affiliation needs both identifiers; a multi-campus university needs the campus-level resolution; an INSERM unit needs both the unit ROR and the parent INSERM ROR.

    RAiD: the project-level PID

    The Research Activity Identifier is the newest of the quartet and is filling a real gap. A project (a grant, a clinical trial, a multi-institution collaboration, a piece of fieldwork) was for years the orphan of the PID world: it had no canonical identifier, so its outputs (papers, datasets, software, training of students) could not be reliably linked back to it. RAiD, now an ISO standard (ISO 23527:2022) and operated as an open infrastructure with multiple national service providers, fills the gap.

    The RAiD model is straightforward: a RAiD record names the project, lists its participants (with ORCID iDs), its institutions (with ROR IDs), its outputs (with DOIs and other PIDs), its funders (with ROR or Funder Registry), its dates, and its status. A funder issues or registers a RAiD on award; the awardees update it as the project evolves; the outputs reference it.

    In 2026 RAiD adoption is strongest in Australia (where the ARDC operates a national RAiD service), New Zealand, the UK (where UKRI has integrated RAiD into its funding workflow), and parts of the EU. North American uptake has been slower; NIH’s evolving project-identifier approach overlaps with but is not identical to RAiD, and the harmonisation is still in negotiation.

    DOIs across artefact types

    The Digital Object Identifier is the workhorse. The interesting story in 2026 is not DOIs for journal articles (a settled problem) but DOIs for everything else.

    • Data. DataCite issues DOIs for datasets; coverage is high in well-funded disciplines (biology, astronomy, climate, social sciences via ICPSR), lower in others. The FAIR-data push has pulled coverage up.
    • Software. Software DOIs via Zenodo and via journal-specific archives (e.g., Software Impacts, JOSS) are now standard practice. Citation of software with DOIs is endorsed by the FAIR4RS principles.
    • Preprints. Every major preprint server issues DOIs; the Crossref preprint relationship metadata links the preprint DOI to the eventual journal-article DOI.
    • Preregistrations. OSF and AsPredicted issue preregistration DOIs.
    • Samples. IGSN (International Generic Sample Number) is a specialised PID for physical samples, increasingly issued as a DOI under the DataCite umbrella.
    • Instruments. The PIDINST initiative is rolling out DOIs for major research instruments, with full metadata about specifications and operators.

    The crosswalk layer

    The most underrated work in the PID ecosystem is the crosswalk layer: the mappings between identifier systems that make the quartet actually function as a graph. Crossref’s references and relations blocks link DOIs to other DOIs and to other PIDs. DataCite’s relatedIdentifier field plays the same role for datasets. ORCID’s work entries carry DOIs and increasingly RAiDs. ROR records carry relationships to other organisations and to Funder Registry entries.

    Where crosswalks fail is at the institutional repository boundary. A paper deposited in a university IR may have a DOI, but the IR record’s author affiliation may not resolve to a ROR ID; the project funding may be in a free-text field rather than a Funder Registry ID; the dataset associated with the paper may have a DOI but no relation to the paper’s DOI declared. The result is a graph with broken edges, which then degrades discovery downstream.

    The work to fix this in 2026 is mostly unglamorous metadata QA at the repository and CRIS layer. Several institutional CRIS vendors have shipped “PID completeness” dashboards that flag records with missing or unresolvable identifiers. The OpenAIRE Graph project rolls up the global picture and is the most useful external check.

    What we expect to settle by 2027

    Three threads are in motion. First, contributor-affiliation provenance: an ORCID record’s affiliation history with PIDs at both ends will become the canonical record, replacing the per-publisher author-affiliation strings that journals still maintain separately. Second, funder-PID standardisation: the Crossref Funder Registry and ROR are converging, with funders that are also research organisations getting unified records. Third, project-PID interop: RAiD, NIH project IDs, and the EU’s HORIZON identifiers are being mapped to allow a single project to be tracked across funder boundaries.

    For institutions setting strategy now, the practical priorities are: require ORCID at hire and on every publication; map every internal organisation to ROR; integrate RAiD into the funding-receipt workflow if you have it; and run quarterly QA against your CRIS for missing PIDs. The CRIS guidance at CASRAI walks through the integration patterns by vendor.

    Related dictionary entries

    References

    Meadows et al., Persistent Identifiers: The Building Blocks of the Research Information Infrastructure (Information Services and Use, 2019). Cousijn et al., A data citation roadmap for scholarly data repositories (Scientific Data, 2019). FAIR4RS Working Group, FAIR Principles for Research Software (RDA, 2022). ARDC documentation on RAiD operational service. ROR governance documentation and CC0 data dumps.

  • Reading the RDA DMP Common Standard v2 changelog

    The Research Data Alliance’s DMP Common Standard, originally published as v1 in 2019, has been the canonical machine-readable schema for machine-actionable data management plans. The v2 revision, released early in 2026 after a two-year community consultation, reorganises the schema, tightens validation, and adds explicit support for software, samples, and instruments alongside data. This post is a field-by-field walkthrough for integrators.

    Why v2 was needed

    v1 was designed in the FAIR-data heyday and is fit for that purpose. Three forces produced the v2 revision. First, the scope of “things to be managed” expanded: software is increasingly part of the planning conversation, samples are increasingly recognised as research outputs that need governance, instruments have their own management lifecycle. v1 could be coaxed into representing these but the structure was uncomfortable. Second, validation: v1 was permissive in the ways that mature standards usually tighten over time. Optional fields proliferated, the meaning of several fields was under-specified, and tools produced incompatible serialisations within nominal compliance. Third, FAIR-implementation maturity: v2 needed to carry the metadata that the FAIR data-assessment frameworks (FAIRsharing, F-UJI, FAIR Implementation Profiles) had converged on requiring.

    Structural changes

    The top-level structure of v2 is reorganised. v1 had dmp as the root with sub-resources for dataset, contact, contributor, project, cost. v2 keeps dmp as the root but moves to a managed_resources array that contains heterogeneous resource types: dataset, software, sample, instrument, other. Each resource type has its own schema with shared common fields (identifier, title, description, distribution, license, contributors with CRediT roles) and type-specific fields.

    This is the biggest structural change and the one that will require migration effort. v1 DMPs with only datasets can be projected into v2 cleanly; v1 DMPs that used the dataset structure to represent software or samples (the common workaround) will need restructuring on migration.

    Identifier requirements

    v2 tightens identifier requirements. Every managed resource must declare its identifier with a type (DOI, Handle, URL, ARK, IGSN for samples, RAiD for projects); the identifier validation runs against the type. The contributor structure requires ORCID iDs for individuals; the affiliation structure requires ROR IDs for organisations. The project structure requires either a RAiD or a Funder Registry grant identifier or both.

    The validation tightening is the integration-relevant change. v1 tools that accepted strings in identifier fields will produce DMPs that fail v2 validation. Integrators should review their PID-handling logic before migrating.

    The CRediT integration

    v2 carries CRediT roles natively in the contributor structure. Each contributor on a DMP can be assigned one or more CRediT roles with the degree-of-contribution qualifier. The expected pattern is that DMP contributors (the people who will manage the data) get roles like Data curation, Resources, Project administration, Supervision, with the actual research contributors getting their roles assigned later via the publication or dataset metadata. The DMP captures the data-management contributorship, not the research contributorship.

    FAIR alignment

    v2 includes a fair_assessment structure that aligns with the FAIR Implementation Profile framework. Each managed resource can carry an FIP reference, and the DMP-level fair_assessment can declare which FAIRsharing-registered standards, identifiers, and policies the resources conform to. This is the bridge between DMP-as-planning-document and DMP-as-FAIR-compliance-record.

    The cost structure

    v2 reworks the cost structure. v1 had a flat cost array with title, description, value, currency. v2 categorises costs by phase (acquisition, processing, storage-active, storage-preservation, dissemination, decommissioning) and by recurrence (one-off versus annual), which lets a DMP integrate with funder budget structures and institutional cost-recovery models. The cost structure is optional but recommended.

    Lifecycle status

    v2 introduces an explicit lifecycle field on each managed resource, with controlled values covering planning, acquisition, processing, analysis, dissemination, preservation, decommissioning. A DMP can describe resources at different lifecycle stages, which lets the same DMP serve as both a project-launch plan and a project-completion record. This addresses a v1 friction where DMPs were either pre-project plans or post-project records and the same document could not serve both purposes cleanly.

    Migration path

    RDA’s recommendation is that v1 DMPs remain valid through 2027 and that v2 DMPs become the preferred format from 2026. Tools producing or consuming DMPs should support both formats during the transition window. The official RDA migration guide covers the field mappings; the CASRAI maDMP domain tracks tool-vendor support as it rolls out.

    Specific migration considerations: v1 datasets representing software should be re-categorised as v2 software resources; v1 datasets representing samples should be re-categorised as v2 sample resources; v1 contributors without ORCID iDs need ORCID iDs added before v2 validation will pass; v1 organisational affiliations need ROR IDs.

    Tool support

    By the v2 release, the major DMP tools (DMPonline, DMPTool, easyDMP, ARGOS) had announced support timelines. DMPonline and DMPTool committed to v2 export support in mid-2026 with import support later in the year. easyDMP shipped v2 support at the v2 release. ARGOS has v2 support in beta. Institutional and funder DMP services built on these tools inherit their support timelines.

    The funder side of the integration is also moving. Several major funders had been ingesting v1 DMPs in machine-readable form for compliance tracking; the v2 transition gives them an opportunity to tighten ingestion validation and to use the richer FAIR-assessment structure. The CASRAI funder maDMP guide walks through the funder-side migration.

    What this enables

    The longer-term value of v2 is in the queries it enables across machine-readable DMPs at scale. A funder can ask: across all funded projects starting in 2026, which fraction declared FAIR-compliant deposit plans for their datasets, software, and samples? — and get a structured answer. An institution can ask: which projects on our books have DMPs that declare preservation costs, and what is our aggregate preservation-cost commitment? — and get a structured answer. v1 made these queries notionally possible; v2 makes them reliable.

    For research administration, the practical posture in 2026 is to follow the funder migration. Where funders require v2, migrate; where they still accept v1, produce both. The migration is one-way (a v2 DMP cannot be cleanly downgraded to v1 if the new resource types are used) but the v1-to-v2 path is well-supported.

    Related dictionary entries

  • Plan S and Diamond OA: where the open-access conversation is going

    Seven years after Plan S was announced and five years after its 2021 implementation deadline, the open-access conversation in 2026 looks meaningfully different from what its architects expected. The APC-plus-Read-and-Publish trajectory that dominated 2019-2023 is now competing with a much louder Diamond OA movement, with Subscribe-to-Open playing a quiet but important supporting role, and with sharp critique of the inequity that APC-based OA has reinforced. This post walks through the current state of the conversation and what we expect to see settle by 2027.

    Plan S compliance in 2026

    Plan S, the policy framework launched by cOAlition S in 2018, required that recipients of cOAlition S funder grants make their resulting publications immediately open access under a CC BY licence, via one of three routes: publication in a fully OA journal, publication in a hybrid journal under a transformative agreement, or self-archiving in a repository (the green route) without embargo and with retained rights.

    By 2026 the picture is mixed but not in the directions originally feared. Compliance among cOAlition S funder grantees is high (above 90% in the most recent monitoring report) but the modal route is no longer transformative agreements; it is rights-retention deposit. The Rights Retention Strategy, in which authors apply a CC BY licence to the accepted manuscript regardless of journal policy, has been quietly successful. By 2026 most major publishers have either explicitly accommodated RRS or stopped fighting it.

    The transformative-agreements track did not transform the publishing economy as cOAlition S had hoped. Read-and-Publish deals at the consortium and country level moved a lot of money from subscriptions to APCs but did not significantly change the underlying cost or the publisher consolidation. The funder-led price transparency requirement (Plan S has required publishers to disclose service-based pricing for some years now) has produced data but not yet pressure.

    The Diamond OA inflection

    The biggest shift in 2024-2025 was the move of significant funder attention from APC-based Gold OA to Diamond OA: journals that charge neither authors nor readers, funded instead by institutions, learned societies, libraries, and consortia. The 2023 Action Plan for Diamond Open Access from Science Europe, cOAlition S, OPERAS, and the French ANR, followed by the 2024 launch of the Diamond Open Access Capacity Centre, materially changed the funding landscape for community-led journals.

    By 2026 the visible result is a wave of new and renewed Diamond OA journals, particularly in the humanities and social sciences where APCs have always sat uncomfortably with the discipline’s economics. The OPERAS DOAB and DOAJ now flag Diamond OA journals explicitly. The 2024 Plan Diamond joint declaration committed signatory funders and institutions to channelling a defined fraction of OA-related spending into Diamond OA infrastructure.

    The structural challenge for Diamond OA remains sustainability. A journal funded by a single consortium is one budget cycle away from disappearing. The current direction is to pool funding across consortia and to professionalise the support layer (production, hosting, copy-editing, indexing) rather than reinventing it per journal.

    Subscribe-to-Open

    Subscribe-to-Open deserves more attention than it receives. The S2O model, pioneered by Annual Reviews and now adopted by EDP Sciences, Berghahn, and a growing list of others, asks the existing subscribers to continue paying their subscriptions; if enough do, the journal flips to open access for that year. If the threshold is not met, the journal stays subscription. The mechanism preserves a sustainable revenue model while flipping content to OA without APCs.

    S2O has been remarkably durable. Annual Reviews has hit the threshold every year of the programme; Berghahn flipped over thirty journals to S2O across humanities and social sciences. The model is constrained: it works for journals with a substantial existing institutional subscriber base, less well for new journals or for those without an institutional market. But where it fits, it works, and it sidesteps the APC-inequity problem entirely.

    Read-and-Publish agreements: the messy middle

    Read-and-Publish (also called Transformative Agreements) bundle subscription access and APC publishing into a single contract between a library consortium and a publisher. They peaked in deal-volume around 2022-2023 and have plateaued since.

    The criticisms have sharpened. R&P deals concentrated OA publishing capacity in well-resourced consortia (Germany’s Project DEAL, the UK’s JISC deals, the Dutch and Swedish consortia). Authors at unsupported institutions, particularly outside the wealthy world, faced full APCs while their better-resourced peers published OA “for free” under their consortium’s deal. The result was an inequity that the OA movement explicitly set out to remove and instead repackaged.

    cOAlition S’s commissioned review in 2023 concluded that transformative agreements had not produced the cost decrease that would justify their continued central role and recommended a transition away from them. By 2026 several major consortia are renegotiating R&P deals into a hybrid of capped APC pools, fee waivers for unaffiliated authors, and Diamond OA investments. The direction of travel is clear; the speed is slow.

    The equity reframing

    The phrase bibliodiversity entered the open-access conversation in 2018 via the Jussieu Call and has steadily gained traction since. It captures something the Plan S framing missed: openness alone does not address the dominance of English-language, Global-North-headquartered, APC-funded publishing. A genuinely equitable scholarly communication system needs multiple languages, multiple regional infrastructures, and multiple economic models, not just open access to the existing system.

    The 2024 UNESCO Recommendation on Open Science, and the 2024-2025 work by the cOAlition S successor strategy group on “equity in scholarly communication,” both center bibliodiversity. The practical translation is that funders are increasingly willing to count regional-language publication, Diamond OA, and community-led infrastructure as legitimate research outputs, not as second-tier venues.

    The push intersects with responsible assessment: as long as assessment privileges high-impact English-language journals, no amount of OA policy will rebalance global publishing. DORA, CoARA, and the Hong Kong Principles all argue for that broader reform, but the mechanics of changing institutional promotion and tenure committees lag the policy by years.

    Where the global South is going

    SciELO (Latin America), AJOL (Africa), J-STAGE (Japan), and similar regional infrastructures are the underacknowledged backbone of global Diamond OA. They have operated for decades on a model that flagship Plan S signatories are belatedly endorsing. The 2024-2025 conversation has shifted from “how do we bring Global South authors to Global North journals” to “how do we recognise and resource the regional infrastructures that already publish them.” cOAlition S has begun direct funding agreements with several regional infrastructures.

    The peer-review and quality-assurance question that historically dogged regional infrastructures has not gone away, but it has changed shape. AJOL and SciELO have invested heavily in DOAJ-aligned editorial practice; the data show their journals’ peer-review rigour comparable to similarly-scoped Global North journals. The reputational gap that remains is mostly a function of bibliometric assessment patterns, not editorial quality.

    What’s coming in 2026-2027

    Three things to watch. First, the second wave of Plan S: cOAlition S has signalled that its next-phase strategy (drafted through 2025, expected in mid-2026) will pivot toward Diamond OA, equity, and the de-prioritisation of transformative agreements. Second, institutional re-investment: as R&P deals expire, libraries are increasingly redirecting their formerly subscription budgets into open infrastructure (Diamond OA, preprint servers, institutional repositories). The MIT Framework and similar institutional principles are influential here. Third, cross-funder coordination: the gap between cOAlition S funders and the major North American funders (NIH, NSF, the Tri-Agencies in Canada) has narrowed; OSTP’s 2022 memo and its 2026 implementation are pushing the US system in a similar direction, though through different mechanisms.

    For authors, the practical advice is unchanged: deposit your accepted manuscript in your institutional repository under a CC BY licence using the rights-retention model; choose Diamond OA where it exists and serves your community; choose Gold OA in journals with transparent pricing where it does not; resist the assumption that the journal-impact-factor ladder is the path to a sustainable career.

    Related dictionary entries

    References

    cOAlition S, Plan S Principles and Implementation Guidance (2018, revised 2020). Science Europe, cOAlition S, OPERAS, ANR, Action Plan for Diamond Open Access (2023). Jussieu Call for Open Science and Bibliodiversity (2018). UNESCO, Recommendation on Open Science (2021, with 2024 implementation report). Suber, Open Access (MIT Press, revised 2024).

  • The case for narrative CVs beyond UKRI

    The UK Research and Innovation Resume for Research and Innovation (R4RI), launched in pilot in 2019 and now the default CV format across UKRI’s seven research councils, has accumulated enough operational experience to draw lessons. The narrative-CV approach has spread internationally: the Dutch Research Council, the Swiss National Science Foundation, the Royal Society’s CV format, parts of the EU’s Horizon Europe evaluation, and several US private funders have adopted variants. Where it has not spread is the major US federal funders. This post argues the case for broader adoption with reference to the UKRI experience.

    What R4RI is

    R4RI replaces the traditional publication-list CV with a structured narrative covering four modules: how the researcher has contributed to the generation of new ideas, tools, methodologies, or knowledge; how they have contributed to the development of others; how they have contributed to the wider research community; how they have contributed to broader research and innovation users and audiences, and the wider environment. Each module has a 250-word limit and the researcher provides specific evidence.

    What R4RI explicitly does not ask for: lengthy publication lists, journal impact factors, h-indexes, citation counts, exhaustive grant histories. The Resume for Research and Innovation can include publications but as evidence of contribution, not as a metric.

    Five years of operational experience

    UKRI’s commissioned evaluations of R4RI (published 2022, 2024) and the broader literature on narrative-CV use have produced a reasonably clear picture.

    First, reviewer time. The early concern was that narrative CVs would take longer to review than conventional ones. The evaluation data show modest increases for first-time reviewers, settling to comparable or shorter review times once reviewers were familiar with the format. Reviewers report that R4RI gives them a clearer picture of the applicant’s actual contribution.

    Second, applicant time. Writing an R4RI takes longer than updating a publication list, and applicants without writing support are at a disadvantage. The equity implication is real: a researcher with access to research-administration support to help draft R4RI does better than one without. UKRI has invested in writing-support resources and several institutions have built internal capacity.

    Third, career-stage equity. Narrative CVs perform better for early-career researchers whose publication record is short but whose contribution is significant; they perform better for researchers with non-traditional career paths; they perform better for researchers in disciplines where high-impact publication is not the norm. They perform less well for researchers with very strong conventional records who feel the narrative format does not adequately recognise their publications. On balance the evaluation suggests narrative CVs reduce systemic bias against under-represented career patterns.

    Fourth, inter-rater reliability. The concern that narrative CVs would produce more variable assessment than metric-based CVs has been partially borne out: inter-rater reliability is somewhat lower for R4RI than for conventional CVs. This is in part a feature, not a bug — different reviewers genuinely weight different contributions differently, and the narrative CV surfaces those judgements. UKRI has responded with reviewer-training resources and structured rubrics.

    Why other funders should adopt narrative CVs

    Four reasons.

    First, narrative CVs operationalise DORA and CoARA commitments in a concrete way. A funder that has signed DORA but continues to use publication-metric CVs is operating in contradiction with its commitment; a funder that adopts a narrative CV format is operationalising it. The CASRAI responsible assessment domain tracks the gap between policy and practice across major funders.

    Second, narrative CVs make CRediT more useful. A CV that reports CRediT roles for the applicant’s recent papers gives the reviewer specific information about contribution; a publication list without CRediT gives only the byline order. The integration is operationally simple: narrative CVs cite specific contributions, CRediT statements describe what the contribution was.

    Third, narrative CVs reduce the metric-feedback loop. The pernicious cycle in which researchers chase high-impact-factor publications because funders weight them and funders weight them because researchers seek them is one of the system pathologies that responsible-assessment reform aims to break. A narrative CV format breaks the funder side of the loop, which gives researchers permission to optimise differently.

    Fourth, narrative CVs encode the broader range of contributions that modern research actually requires. Software, datasets, public engagement, peer review, mentorship, leadership of community-led infrastructure, contributions to open standards — none of these show up well in a conventional CV. They show up in a narrative CV. The CASRAI institutional responsible-assessment guide includes a checklist of contribution types that narrative formats can capture.

    The objections, addressed

    Three objections recur and deserve direct responses.

    Narrative CVs are subjective and unscientific. The metric-based CV is also subjective: someone decided which metrics to weight, what the weighting should be, and what counts as success. Narrative CVs make the subjectivity explicit and reviewable; metric-based CVs hide it behind a number.

    Narrative CVs disadvantage non-English-speakers. The concern is real and the mitigation is to allow CVs in the applicant’s working language with translation support funded by the funder. UKRI does not currently allow non-English R4RIs because UKRI operates in English; an international funder with multilingual operations would need to.

    Narrative CVs are too long for high-volume review. The 250-word-per-module limit and the four-module structure produce a CV that is no longer than a conventional 5-page academic CV; in many cases shorter. The objection is empirically wrong as stated.

    Practical recommendations

    For funders considering adoption, the practical steps are: pilot with one or two grant streams; train reviewers with worked examples; develop a structured rubric for scoring; provide writing-support resources for applicants; commit to an evaluation at year three; iterate the format based on the evaluation. UKRI’s experience suggests this approach yields a usable format within three years.

    For institutions supporting applicants, the practical steps are: build internal capacity to support narrative-CV drafting; offer it equitably across career stages and disciplines; treat it as part of the research-administration support package, not as an exceptional service for senior researchers only.

    For applicants, the practical advice is to start drafting in a narrative format now, even where the funder does not require it. The discipline of articulating contribution rather than enumerating publications produces a richer self-understanding of one’s own research and is useful for promotion, tenure, and personal career planning regardless of funder requirements.

    The trajectory

    We expect narrative-CV adoption to accelerate through 2026-2028. The CoARA commitment to reforming research assessment, combined with the maturity of the R4RI model, gives funders a credible template to adopt. The remaining holdouts are the major US federal funders (NIH and NSF), whose biosketch and current-and-pending-support formats are partial moves toward narrative but retain substantial metric content. The next round of US-funder review-criteria revision will be the test.

    Related dictionary entries